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Background: Spontaneous liver bleeding (SLB) is a rare but potentially fatal complication. In contrast to
the East, various benign pathologies are the source of SLB in the West. An accurate diagnosis and a
timely implementation of appropriate treatment are crucial in the management of these patients. The
present study presents a large Western experience of SLB from a specialist liver centre.
Methods: A retrospective analysis of patients presented with SLB between January 1995 and
January 2011.
Results: Sixty-seven patients had SLB, 44 (66%) were female and the median age at presentation was
47 years. Abrupt onset upper abdominal pain was the presenting symptom in 65 (97%) patients. The
aetiology for SLB was hepatic adenoma in 27 (40%), hepatocellular carcinoma (HCC) in 17 (25%) and
various other liver pathologies in the rest. Emergency treatment included a conservative approach in 42
(64%), DSA and embolization in 6 (9%), a laparotomy and packing in 6 (9%) and a liver resection in 11
(16%) patients. Eleven (16%) patients had further planned treatments. Seven (10%) died during the same
admission but the mortality was highest in patients with HELLP syndrome. At a median follow-up of 54
months all patients with benign disease are alive. The 1-, 3- and 5-year survival of patients with HCC was
59%, 35% and17%, respectively.
Conclusion: SLB is a life-threatening complication of various underlying conditions and may represent
their first manifestation. The management should include initial haemostasis followed by appropriate
staging investigations to provide a definitive treatment for each individual patient.
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Introduction
Spontaneous liver bleeding (SLB) was first described in 1844 but
remains a rare complication associated with various underlying
predisposing conditions.1 The clinical presentation is often non-
specific but potentially life threatening and therefore demands a
prompt diagnosis and treatment. The emergency scenario could
be further complicated by the presence of advanced liver dis-
ease rendering its appropriate management a great therapeutic
dilemma and resulting in poor outcomes.2 In contrast to the East
where an underlying hepatocellular carcinoma (HCC) is the pre-
dominant cause, a variety of benign pathologies dominated by
hepatic adenoma is the aetiology for SLB in the West. Various
treatment options have been proposed but it is the sound
decision-making process involving a multidisciplinary team,
taking into account all the patient- and disease-specific param-
eters, that play the most crucial role in the patient outcomes.3
The present study describes the aetiology, clinical presentation,
management and outcome of patients who were diagnosed with
SLB in a tertiary referral centre.
The abstract was an oral presentation at the recent APHPBA congress in
Melbourne.
DOI:10.1111/j.1477-2574.2012.00460.x HPB
HPB 2012, 14, 382–389 © 2012 International Hepato-Pancreato-Biliary Association
Patients and methods
The centre where this study was conducted provides specialist
hepatobiliary pancreatic and liver transplant services. A retrospec-
tive search was performed using the prospectively managed liver
unit database to identify all patients who presented with SLB
between January 1995 and January 2011. Data regarding clinical
presentation, diagnosis, any underlying predisposing condition
and the treatment implemented were collected. In patients
diagnosed with hepatocellular carcinoma, the status of their
background liver, their liver function reserve according to the
Child–Turcotte–Pugh (CTP) score and the potential underlying
aetiology of their primary liver cancer were also recorded. Tumour
markers including carcinoembryonic antigen (CEA), carbohy-
drate antigen CA19-9 and alpha-fetoprotein (AFP) were mea-
sured if there was any clinical suspicion of an underlying tumour.
The primary outcome measure was patient survival. Complete
clinical and follow-up data were available for all patients.
Results
During the study period a total of 4271 malignant and 2275
benign hepatobiliary patients were referred to the unit. A diagno-
sis of SLB was made in 67 patients and they were included in the
present study. The median age at presentation was 47 years (range
21–76) and 44 (66%) were female. Sixty-five patients (97%) were
referred after their initial evaluation and stabilization at local hos-
pitals. Two (3%) were admitted directly after an incidental diag-
nosis of a subcapsular liver hematoma on imaging performed for
evaluation of abnormal liver function tests.A detailed summary of
clinical presentation is presented in Table 1.
Sixty-four of the 67 patients (95%) were submitted to a
contrast-enhanced computed tomography scan (CE-CT) of the
abdomen and pelvis at the referring hospital after initial resusci-
tation. One patient (2%) was evaluated only by an abdominal
ultrasonography (US), and 2 (3%) underwent an emergency lap-
arotomy and packing prior to imaging. After transfer from the
referring hospitals, all patients were re-assessed using triple-phase
CT. Eight patients (12%) underwent selective digital subtraction
angiography (DSA) of the coeliac axis and superior mesenteric
artery, with or without embolization. Magnetic resonance
imaging (MRI) was performed in 54 patients (81%) for further
characterization of lesions detected on a CT scan. The imaging
revealed that 23 (34%) presented with haemoperitoneum, 36
(54%) with a subcapsular liver hematoma and 8 patients (12%)
with a combination of a subcapsular hematoma and intra-
peritoneal bleeding. Selected images are presented as Figs 1–4.
A detailed summary of the underlying aetiology for SLB in the
present study along with the total number of patients diagnosed
with that specific underlying pathology during the study period
are presented in Table 2.
Six patients (9%) were taking aspirin at the time of presentation
(2 with HCC, 2 with adenoma and 2 with hematoma and no
underlying lesion). One patient (2%) with polycystic liver disease
was on warfarin and 2 (3%) (1 with peliosis hepatis and 1 with a
haematoma and no underlying pathology) were on treatment-
dose low-molecular-weight heparin (enoxaparin). In addition, the
oral contraceptive pill and hormone replacement therapy were
among the prescriptions of 6 (9%) and 4 patients (6%) with a
ruptured adenoma, respectively. Six patients (9%) (1 without any
lesion, 3 with adenoma and 2 with peliosis hepatis) were receiving
anabolic steroids.
Among the 17 HCC patients, 15 were cirrhotic and the under-
lying liver disease was of viral aetiology in 10. Of the 15 cirrhotic
patients, 3 were CTP class A, 4 were class B and 8 were class C. The
levels of AFP were elevated in 10 HCC patients. A diagnosis of
HCC was established in 9 patients prior to presentation with SLB.
Of the 27 patients diagnosed with adenoma 3 had a known history
of multiple adenomatosis. The median follow-up period was 54
months (range 0–193 months).
Management
Adenoma (n = 27)
Twenty-two patients were successfully managed without any
intervention. Two patients required selective hepatic artery embo-
lization, and three patients underwent an emergency liver resec-
tion (two right hepatectomy and one left hepatectomy). There
were no peri-operative deaths. All patients with ruptured
adenoma were subsequently followed-up with abdominal US
examination every 6 months for the first year and annually
thereafter.
During follow-up, two patients had a left lateral segmentectomy
(7 months after the bleeding episode), one underwent a right
extended hepatectomy (12 months post discharge) and one had a
right lobectomy (2 years after rupture) for a sudden increase in
tumour size. At a median follow-up of 57 (range 17–193) months
all patients were alive.
HCC (n-17)
Twelve patients were managed conservatively and of these only
one was non-cirrhotic. Three patients who received palliative
treatment owing to advanced liver disease died during the same
admission. A selective DSA and embolization was performed in
Table 1 Presenting signs and symptoms of spontaneous liver bleed-
ing in our study group (n = 67)
Symptoms and signs n (%)
Abdominal pain 65 (97)
Malaise 53 (79)
Vomiting 42 (63)
Hematemesis 1 (2)
Retrosternal pain 4 (6)
Fever 1 (2)
Jaundice 5 (8)
Hypovolemic shock 8 (12)
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two patients. Three patients underwent a hepatic resection during
the same admission after control of haemorrhage surgery; one
patient without cirrhosis had a left hepatectomy but died 20
months later because of distant metastases. The second patient
(CTP class A cirrhosis) underwent a non-anatomical resection of
the lesion and is still alive 5 years after surgery. The third patient
who underwent a laparotomy for haemostasis at the local refer-
ring hospital had peritoneal disease and died 2 months later. The
in-hospital mortality for the HCC group of patients was 3 out of
17 patients.
After initial haemostasis, patients who received conservative
treatment had definitive treatment for the underlying tumour as
follows: transarterial chemoembolisation (TACE) in 3, radiofre-
quency ablation (RFA) +/- TACE in 2, a left hemihepatectomy 2
months after discharge in 1 patient, an extended left hepatectomy
4 months after discharge in 1 and palliative treatment for 4
patients. The 1-, 3- and 5-year survival was 59%, 35% and 17%,
respectively.
Metastases from colorectal primary (n = 2)
One of the two patients with metastatic adenocarcinoma of col-
orectal origin was managed conservatively and the other with
packing. Both died within the first year after their discharge.
Other benign pathologies
Four patients with polycystic liver disease were initially managed
conservatively and subsequently evaluated for potential treatment
options. Two patients underwent laparoscopic de-roofing of cysts
3 and 12 months after SLB for symptom relief. All patients are
alive at a median follow-up of 65 months (range 48–96).
One patient with nodular regenerative hyperplasia underwent
an emergency right hepatectomy after failed radiological control
of a haemorrhage. The patient is alive at 4 years follow-up.
One of the two patients with peliosis hepatis underwent an
emergency laparotomy and packing at a local hospital but unfor-
tunately died 24 h later. The second patient underwent DSA
embolization and is alive 56 months after discharge.
Of the four patients with HELLP syndrome, two underwent a
right hemihepatectomy for a right liver lobe infarction and necro-
sis and the others had an emergency laparotomy for haemostasis.
Three of them died during the immediate post-operative period.
The fourth patient is alive 13 years after the right hepatectomy.
Both patients with ruptured hepatic artery pseudoaneurysms
owing to underlying PAN were successfully managed conserva-
tively, and are alive 8 and 35 months after SLB.
The patient diagnosed with an underlying hemangioma was
managed conservatively. Two of the 3 patients with focal nodular
hyperplasia underwent a right hemihepatectomy and one had a
left lateral segmentectomy. All patients diagnosed with either
hemangioma or FNH remain alive at the latest follow-up.
(a) (b)
Figure 1 (a) Computed tomography and (b) magnetic resonance imaging images of a patient with spontaneous liver bleeding
Figure 2 Computed tomography arterial phase-spontaneous liver
bleeding with an underlying mass in the right lobe of the liver hepa-
tocellular carcinoma
Figure 3 Computed tomography venous phase-right lobe (seg 6/7)
intra-capsular haematoma owing to a ruptured hepatic adenoma
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Of the 3 patients with spontaneous liver rupture without iden-
tified underlying pathology, 1 patient was managed conservatively
and is alive at follow-up. One underwent a right hepatectomy and
remains alive 84 months after treatment. The last patient who
underwent an emergency laparotomy and packing died on the
second.
The emergency management of patients presenting with SLB is
outlined as a flow sheet in Fig. 5.
Discussion
Spontaneous liver bleeding is a rare life-threatening complica-
tion that warrants a timely diagnosis and effective control of
haemorrhage. The presenting symptoms are often non-specific
and SLB may also be the first manifestation of an unknown
malignant or benign liver tumour. Fifty-nine (92%) patients in
the present study presented with non-specific signs and symp-
toms. Some authors have reported an accurate pre-surgical diag-
nosis of SLB in only 60% of patients.4 Careful history and
physical examination in conjunction with appropriate diagnostic
work-up can help to establish the correct diagnosis. A triple
phase CT scan of the abdomen and pelvis was the imaging
modality of choice used for assessment of patients in the present
study. A multi-detector CT (MDCT) scan has higher sensitivity
and resolutional capacity than ultrasonography and it is faster
and more easily accessible in emergency situations compared
with MRI.5,6 A conventional angiography remains the gold stan-
dard for the diagnosis of an active hemorrhage8; however, the
improvement in sensitivity of MDCT placed it at the frontline
of the diagnostic armamentarium.7,9,10 The pathognomonic CT
finding in the acute setting is active contrast extravasation and
depiction of an area of blush with attenuation values similar to
or greater than that of an adjacent enhancing vessel.10 In cases of
demonstrated active bleeding, the implementation of selective
visceral angiography with embolization of the bleeding arterial
branches offers an opportunity of managing the patient in a
minimal invasive manner and planning a further therapeutic
strategy in an elective setting, as demonstrated in this series.
Occasionally the only initial finding on US or a CT scan per-
formed as an emergency is a subcapsular hematoma secondary
to bleeding of a small underlying lesion in the periphery of the
liver that is not detected by imaging.11,12 The stabilization of the
patient with conservative measures, such as the embolization of
the feeding arteries of the lesion, allow the attending multidis-
ciplinary team to repeat the CT scan or employ MRI imaging for
better characterization of the cause of the hemorrhage and defi-
nite management of the patient.
The majority of the published literature describing SLB is
from the East where the high incidence of HCC makes it the
most common underlying cause for bleeding. The management
and outcomes of a ruptured HCC very much depend on the
severity of underlying liver disease. In this current series the
most frequent cause of spontaneous liver bleeding was hepatic
adenomas (27 patients, 40%). Hepatic adenomas usually occur in
young women on long-term oestrogen therapy13,14 and the risk of
a rupture may be as high as 30% to 50% in tumours >4 cm.15–17
The management of patients with bleeding hepatic adenomas
depends on their hemodynamic status at the time of admission.
Figure 4 Spontaenous liver bleeding in a patient with underlying vasculitis
Table 2 Underlying aetiology for spontaneous liver bleeding (SLB)
(n = 67)
Underlying pathology for
SLB
n Total number of
patients diagnosed
in study period
Benign Adenoma 27 101
Hepatocellular cancer (HCC) 17 841
Polycystic liver disease 4 36
Simple liver cyst 1 130
Polyarteritits nodosa (pseudoaneurysms) 2 2
HELLP syndrome 4 6
Nodular regenerative hyperplasia 1 13
Peliosis hepatis 2 2
Metastatic colorectal adenocarcinoma 2 1884
Focal nodular hyperplasia (FNH) 3 116
Haemangioma 1 77
No underlying pathology 3 –
HCC, hepatocellular cancer; FNH, focal nodular hyperplasia.
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In haemodynamically unstable patients after unsuccessful con-
servative management temporary haemostasis can be achieved
with embolization or ligation of the feeding arterial branches or
even the main hepatic arterial branch.18 Most experts advocate
the delayed resection of the liver adenomas based on the fact that
the natural history of such lesions is unpredictable and the cost
benefit of long-term surveillance of these patients may outweigh
the risks of surgical resection.19,20 In the present study, the
patients who were managed conservatively and those who under-
went successful coil embolization of the feeding vessels were sub-
mitted to a repeat CT scan to exclude pseudoaneurysms or
re-bleed. There were no episodes of re-bleeding in the study
cohort. The follow-up protocol included twice yearly US exami-
nation for the first year and annual US thereafter, along with
measurement of AFP. Only patients with multiple adenoma, pro-
gressive advancement of their tumour size or suspicion of malig-
nant transformation and those who opted for a surgical
treatment subsequently underwent an operation in the form of
some kind of hepatectomy. The incidence of malignancy in the
entire group of patients with adenoma during the study period
Suspected spontaneous liver haemorrhage
Confirm diagnosis
Detailed history of symptoms, past medical history, drug history
ultrasound/tri-phasic CT/liver-specific contrast MRI/angiogram
Conservative management in a high-dependency or intensive care unit
Fluid resuscitation
Warming
Use of blood and appropriate blood products such as fresh frozen
plasma/platelets/cryoprecipitate/recombinant factor Vll a(Novoseven)
Failed conservative treatment with on-going haemorrhage
Emergency angiogram and targeted coil embolization
Surgical control of haemorrhage-
laparotomy and packing/hepatectomy
Successful control of haemorrhage Failed radiological intervention
Re-image (according to clinical
             need or Day 7)
To further characterize underlying
lesion and exclude pseudoaneurysms
Multidisciplinary discussion to plan definitive
treatment and follow-up protocols
Refer to specialist unit after initial stabilization
Figure 5 Algorithm for the management of spontaneous liver bleeding (SLB)
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(101 patients) was 3% but none of them had SLB. Only in
patients where haemostasis could not be attained with conserva-
tive measures, an immediate resection with enucleation or a
partial hepatectomy was the preferred treatment. The treatment
options should be individualized based on the clinical param-
eters and morphology of the underlying adenoma. All offending
medication should be discontinued after a rupture.21,22
The incidence of a spontaneous rupture with HCC is between
3% and 15%.23,24 In the present study, patients with advanced liver
disease or disseminated tumours were managed palliative. If signs
of continued bleeding were clinically or radiologically evident,
attempts at haemostasis with transarterial embolization were
made. After the initial stabilization of the patient and precise
staging of the disease with consideration of all patient- and
tumour-related factors, further curative treatment in the form of a
hepatectomy or palliative therapy in the form of TACE, RFA or
chemotherapy was implemented. More recent studies have shown
that early mortality and the long-term survival rate is not depen-
dent on themodality of treatment but on the patient’s disease state,
CTP class in the presence of cirrhosis, total bilirubin level and the
severity of shock.25–27Anurgent hepatectomywas performed in 2of
the 17 patients after an initial control of the haemorrhage. One
of them was non-cirrhotic and the other was CTP class A, both
of their tumours were small, single and easily accessible.
Polyarteritis nodosa (PAN) is a rare form of systemic vasculitis
that has been associated with visceral artery aneurysm formation
as a result of the underlying transmural inflammation. Gas-
trointestinal involvement is frequently seen in PAN, but isolated
vasculitis of the liver with a ruptured hepatic artery aneurysm is
an extremely rare initial clinical presentation. A clinical diagnosis
is established if 3 of the 10 diagnostic criteria described by the
American College of Rheumatologists (ACR) are present.28 In two
patients who presented with a ruptured hepatic artery pseudoan-
eurysm, the diagnosis of PAN was established using ACR criteria.
In addition to the administration of the appropriate immunosup-
pressive therapy for vasculitis, one of these patients underwent
multiple percutaneous transarterial embolization of the ruptured
pseudoaneurysms. Such cases emphasize the importance of sus-
pecting the presence of some form of vasculitis as the underlying
cause when multiple visceral pseudoaneurysms and other perti-
nent symptoms included in the patient’s history are encountered.
The aim of acute treatment is initial resuscitation followed by
control of the haemorrhage at specialized centres with expert
interventional radiologists. Immunosuppression and, if required,
cytotoxic agents should be promptly commenced which could be
life saving. Long-term follow-up of these patients with interval
radiological imaging is essential.
HELLP syndrome is a multisystemic disorder that complicates
pregnancy or appears soon after delivery. It is frequently associ-
ated with pre-eclampsia or eclampsia. Sudden onset abdominal
pain with anaemia or signs of shock along with evidence of
haemolysis, altered liver tests, and renal dysfunction on blood
profile in the appropriate clinical setting should raise a suspicion
of hepatic rupture. Death results largely from complications
such as disseminated intravascular coagulation, pulmonary
oedema or acute renal insufficiency.29 Aggressive correction of
coagulopathy with blood products and organ supportive treat-
ment in an intensive care setting is critical in the management of
these patients. The grade of hepatic involvement varies from a
minor subcapsular haematoma to an extensive parenchymal
rupture. Transarterial embolization of selected vessels or even
the right or left hepatic artery pedicles should be considered in
patients with extensive parenchymal bleeding. Emergency surgi-
cal treatments are reserved for patients unresponsive to mini-
mally invasive radiological interventions or in the event of
massive hepatic parenchymal necrosis as encountered in two out
of four patients in the present study. Liver transplantation is
indicated in the context of fulminant hepatic failure.30–32 The
outcomes in this group of patients are poor with a very high
in-hospital mortality.
Peliosis hepatis (PH) is a rare condition characterized by the
presence of cystic, blood-filled cavities within the hepatic paren-
chyma. The aetio-pathogenesis of this disease is unclear; however,
injury to the sinusoidal endothelium has been proposed to be the
most likely pathology. Peliosis hepatis may be associated with an
underlying malignancy, acquired immune deficiency syndrome
renal or cardiac transplantation or use of medications such as
anabolic steroids and oral contraceptives.33 A combination of con-
trast CT and MRI is the investigation of choice, early globular
vessel-like enhancement during arterial phase with centrifugal
progression on portal venous and delayed phase without any mass
effect on hepatic vessels is consistent with PH. The natural history
of this disease has not been clearly defined; limited literature in the
form of case reports suggests spontaneous regression or progres-
sion to chronic liver disease or a spontaneous liver rupture.34 In
patients presenting with SLB after control of a haemorrhage,
subsequent management should include stopping the suspected
causative medications or treatment of the associated medical
conditions.
Nodular regenerative hyperplasia (NRH) is a rare lesion that is
associated with non-cirrhotic portal hypertension. The clinical
diagnosis is usually incidental and SLB is an extremely rare initial
presenting symptom. Although histological diagnosis is the gold
standard, a non-invasive clinical diagnosis can be established with
the use of a triphasic CT, liver-specific contrast (Gadolinium,
Primovist) MRI and serum AFP measurement in combination. It
is estimated that NRH is complicated by clinically overt portal
hypertension in more than 50% of patients.35,36 The benign nature
of the lesion and the high incidence of co-existent portal hyper-
tension favour the avoidance of any unnecessary liver resection
even in the presence of complications such as a spontaneous
haemorrhage. The emergency treatment of choice is control of the
haemorrhage by minimally invasive transarterial embolization
followed by investigations to identify any associated diseases.
Patients with NRH have a high incidence (74%) of an associated
malignancy, prothombotic or rheumatological disease.37 The
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definitive treatment after control of the haemorrhage should
include treatment for any concomitant diseases. In those with
associated portal hypertension, the follow-up should aim at
prevention and treatment of complications related to portal
hypertension.
In the present study, two patients presented with SLB with an
underlying metastatic adenocarcinoma of colorectal origin. It is
preferable to achieve haemostasis using conservative means
including embolization and planned surgical management after
patient stabilization.
From the above experience, we suggest that the preferred man-
agement plan for SLB is initial haemostasis using conservative or
radiological embolization methods followed by appropriate
staging investigations to plan a definitive surgical treatment.
Emergency surgery should be reserved for failed conservative and
radiological intervention treatments. In patients with underlying
cirrhosis the outcomes are poor.
In conclusion, spontaneous liver bleeding is a life-threatening
complication of various underlying conditions and may represent
their first manifestation. Benign liver diseases are the predominant
causes for SLB in the West. A high index of suspicion and good
decision making are required for prompt diagnosis of the caus-
ative pathological entity and implementation of appropriate
therapy for each individual patient.
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